A citation-based method for searching scientific literature

Ana Laura Calderón-Garcidueñas, Pablo Ruiz-Flores, Ricardo M Cerda-Flores, Hugo A Barrera-Saldaña. Salud Publica Mex 2005
Times Cited: 24







List of co-cited articles
187 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.
Diana Torres, Muhammad Usman Rashid, Fabian Gil, Angela Umana, Giancarlo Ramelli, Jose Fernando Robledo, Mauricio Tawil, Lilian Torregrosa, Ignacio Briceno, Ute Hamann. Breast Cancer Res Treat 2007
73
58

Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Marcela Gallardo, Antonia Silva, Lorena Rubio, Carolina Alvarez, Carolina Torrealba, Mauricio Salinas, Teresa Tapia, Paola Faundez, Lorena Palma, María Eugenia Riccio,[...]. Breast Cancer Res Treat 2006
52
54

BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico.
Pablo Ruiz-Flores, Olga M Sinilnikova, Michael Badzioch, A L Calderon-Garcidueñas, Sandrine Chopin, Odefrey Fabrice, J F González-Guerrero, Csilla Szabo, Gilbert Lenoir, David E Goldgar,[...]. Hum Mutat 2002
34
50

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil.
Magda C B Gomes, Mauricio M Costa, Radovan Borojevic, Alvaro N A Monteiro, Roberto Vieira, Sergio Koifman, Rosalina Jorge Koifman, Song Li, Robert Royer, Shiyu Zhang,[...]. Breast Cancer Res Treat 2007
57
50

Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.
Felipe Vaca-Paniagua, Rosa María Alvarez-Gomez, Verónica Fragoso-Ontiveros, Silvia Vidal-Millan, Luis Alonso Herrera, David Cantú, Enrique Bargallo-Rocha, Alejandro Mohar, César López-Camarillo, Carlos Pérez-Plasencia. PLoS One 2012
32
50

Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families.
Jeffrey N Weitzel, Veronica I Lagos, Josef S Herzog, Thaddeus Judkins, Brant Hendrickson, Jason S Ho, Charité N Ricker, Katrina J Lowstuter, Kathleen R Blazer, Gail Tomlinson,[...]. Cancer Epidemiol Biomarkers Prev 2007
80
45

Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.
Jeffrey N Weitzel, Veronica Lagos, Kathleen R Blazer, Rebecca Nelson, Charité Ricker, Josef Herzog, Colleen McGuire, Susan Neuhausen. Cancer Epidemiol Biomarkers Prev 2005
131
45

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
Jeffrey N Weitzel, Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth, Cheryl Cina, Paul Duncan, Gary Unzeitig,[...]. J Clin Oncol 2013
113
45

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
Cynthia Villarreal-Garza, Rosa María Alvarez-Gómez, Carlos Pérez-Plasencia, Luis A Herrera, Josef Herzog, Danielle Castillo, Alejandro Mohar, Clementina Castro, Lenny N Gallardo, Dolores Gallardo,[...]. Cancer 2015
65
37

BRCA1 and BRCA2 mutations in a South American population.
Lilian Jara, Sandra Ampuero, Eudocia Santibáñez, Lorena Seccia, Juan Rodríguez, Mario Bustamante, Víctor Martínez, Alejandra Catenaccio, Guillermo Lay-Son, Rafael Blanco,[...]. Cancer Genet Cytogenet 2006
48
33

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba.
Rolando Comacho Rodriguez, Antonio Alejandro Esperon, Ramon Ropero, Maria Caridad Rubio, Ronald Rodriguez, Rosa M Ortiz, Juan J Lence Anta, Mario de los Rios, Deyanira Carnesolta, Maria C del Olivera,[...]. Fam Cancer 2008
28
33

Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.
Gabriela Torres-Mejía, Robert Royer, Marcia Llacuachaqui, Mohammad R Akbari, Anna R Giuliano, Louis Martínez-Matsushita, Angélica Angeles-Llerenas, Carolina Ortega-Olvera, Elad Ziv, Eduardo Lazcano-Ponce,[...]. Cancer Epidemiol Biomarkers Prev 2015
24
33

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.
Esther M John, Alexander Miron, Gail Gong, Amanda I Phipps, Anna Felberg, Frederick P Li, Dee W West, Alice S Whittemore. JAMA 2007
239
29

BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin.
Angela Rosaria Solano, Gitana Maria Aceto, Dreanina Delettieres, Serena Veschi, Maria Isabel Neuman, Eduardo Alonso, Sergio Chialina, Reinaldo Daniel Chacón, Mariani-Costantini Renato, Ernesto Jorge Podestá. Springerplus 2012
37
29

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru.
J Abugattas, M Llacuachaqui, Y Sullcahuaman Allende, A Arias Velásquez, R Velarde, J Cotrina, M Garcés, M León, G Calderón, M de la Cruz,[...]. Clin Genet 2015
39
29

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia.
Julián Esteban Londoño Hernández, Marcia Llacuachaqui, Gonzalo Vásquez Palacio, Juan David Figueroa, Jorge Madrid, Mauricio Lema, Robert Royer, Song Li, Garrett Larson, Jeffrey N Weitzel,[...]. Hered Cancer Clin Pract 2014
33
29

BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.
L Delgado, G Fernández, G Grotiuz, S Cataldi, A González, N Lluveras, M Heguaburu, R Fresco, D Lens, G Sabini,[...]. Breast Cancer Res Treat 2011
17
41

Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families.
Patricio Gonzalez-Hormazabal, Sara Gutierrez-Enriquez, Daniel Gaete, Jose M Reyes, Octavio Peralta, Enrique Waugh, Fernando Gomez, Sonia Margarit, Teresa Bravo, Rafael Blanco,[...]. Breast Cancer Res Treat 2011
35
29

BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela.
Karlena Lara, Nigmet Consigliere, Jorge Pérez, Antonietta Porco. Biol Res 2012
20
35

BRCA1 and BRCA2 mutations among familial breast cancer patients from Costa Rica.
G A Gutiérrez Espeleta, M Llacuachaqui, L García-Jiménez, M Aguilar Herrera, K Loáiciga Vega, A Ortiz, R Royer, S Li, S A Narod. Clin Genet 2012
18
38

Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico.
Julie Dutil, Jose L Colon-Colon, Jaime L Matta, Rebecca Sutphen, Miguel Echenique. Cancer Genet 2012
23
30

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
25

Mutational analysis of BRCA1 and BRCA2 genes in Mexican breast cancer patients.
S Vidal-Millán, L Taja-Chayeb, O Gutiérrez-Hernández, M T Ramírez Ugalde, C Robles-Vidal, E Bargallo-Rocha, A Mohar-Betancourt, A Dueñas-González. Eur J Gynaecol Oncol 2009
14
42

BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.
Kristen J Vogel, Deann P Atchley, Julie Erlichman, Kristine R Broglio, Kaylene J Ready, Vicente Valero, Christopher I Amos, Gabriel N Hortobagyi, Karen H Lu, Banu Arun. J Clin Oncol 2007
50
20

Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history.
Rozany Mucha Dufloth, Sílvia Carvalho, Juliana Karina Heinrich, Júlia Yoriko Shinzato, César Cabello dos Santos, Luiz Carlos Zeferino, Fernando Schmitt. Sao Paulo Med J 2005
31
20

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
20

Absence of the BRCA1 del (exons 9-12) mutation in breast/ovarian cancer families outside of Mexican Hispanics.
Diana Torres, Muhammad U Rashid, Antje Seidel-Renkert, Jeffrey N Weitzel, Ignacio Briceno, Ute Hamann. Breast Cancer Res Treat 2009
17
29


Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity.
Fernando Lara-Medina, Víctor Pérez-Sánchez, David Saavedra-Pérez, Monika Blake-Cerda, Claudia Arce, Daniel Motola-Kuba, Cynthia Villarreal-Garza, Ana Maria González-Angulo, Enrique Bargalló, Jose Luis Aguilar,[...]. Cancer 2011
136
20

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
20

Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil.
V F Esteves, L C S Thuler, L C Amêndola, R J Koifman, S Koifman, P P Frankel, R J S Vieira. Braz J Med Biol Res 2009
19
26

The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.
C Villarreal-Garza, J N Weitzel, M Llacuachaqui, E Sifuentes, M C Magallanes-Hoyos, L Gallardo, R M Alvarez-Gómez, J Herzog, D Castillo, R Royer,[...]. Breast Cancer Res Treat 2015
48
20

Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome.
Ingrid P Ewald, Patrícia Izetti, Fernando R Vargas, Miguel Am Moreira, Aline S Moreira, Carlos A Moreira-Filho, Danielle R Cunha, Sara Hamaguchi, Suzi A Camey, Aishameriane Schmidt,[...]. Hered Cancer Clin Pract 2011
26
20

Breast cancer in Mexico: a pressing priority.
Felicia Marie Knaul, Gustavo Nigenda, Rafael Lozano, Hector Arreola-Ornelas, Ana Langer, Julio Frenk. Reprod Health Matters 2008
60
16

Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer.
Miguel de la Hoya, Sara Gutiérrez-Enríquez, Eladio Velasco, Ana Osorio, Ana Sanchez de Abajo, Ana Vega, Raquel Salazar, Eva Esteban, Gemma Llort, Rogelio Gonzalez-Sarmiento,[...]. Clin Chem 2006
55
16

A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas.
Talia Donenberg, John Lunn, Duvaughn Curling, Theodore Turnquest, Elisa Krill-Jackson, Robert Royer, Steven A Narod, Judith Hurley. Breast Cancer Res Treat 2011
57
16

Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
Felipe C Silva, Bianca Cg Lisboa, Marcia Cp Figueiredo, Giovana T Torrezan, Erika Mm Santos, Ana C Krepischi, Benedito M Rossi, Maria I Achatz, Dirce M Carraro. BMC Med Genet 2014
48
16

Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years.
Kathleen E Malone, Janet R Daling, David R Doody, Li Hsu, Leslie Bernstein, Ralph J Coates, Polly A Marchbanks, Michael S Simon, Jill A McDonald, Sandra A Norman,[...]. Cancer Res 2006
230
16

Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population.
Gabriela Es Felix, Camila Abe-Sandes, Taísa Mb Machado-Lopes, Thaís F Bomfim, Rodrigo Santa Cruz Guindalini, Vanessa Catarine Sar Santos, Lorena Meyer, Polyanna C Oliveira, João Cláudio Neiva, Roberto Meyer,[...]. Hum Genome Var 2014
33
16

BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia.
Alexandra Ortiz Rodríguez, Marcia Llacuachaqui, Gonzalo Guevara Pardo, Robert Royer, Garrett Larson, Jeffrey N Weitzel, Steven A Narod. Gynecol Oncol 2012
48
16

Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.
Dirce Maria Carraro, Maria Aparecida Azevedo Koike Folgueira, Bianca Cristina Garcia Lisboa, Eloisa Helena Ribeiro Olivieri, Ana Cristina Vitorino Krepischi, Alex Fiorini de Carvalho, Louise Danielle de Carvalho Mota, Renato David Puga, Maria do Socorro Maciel, Rodrigo Augusto Depieri Michelli,[...]. PLoS One 2013
56
16

Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.
Juliana Giacomazzi, Marcia S Graudenz, Cynthia A B T Osorio, Patricia Koehler-Santos, Edenir I Palmero, Marcelo Zagonel-Oliveira, Rodrigo A D Michelli, Cristovam Scapulatempo Neto, Gabriela C Fernandes, Maria Isabel W S Achatz,[...]. PLoS One 2014
42
16


Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.
E Warner, W Foulkes, P Goodwin, W Meschino, J Blondal, C Paterson, H Ozcelik, P Goss, D Allingham-Hawkins, N Hamel,[...]. J Natl Cancer Inst 1999
295
12

BRCA1 and BRCA2: 1994 and beyond.
Steven A Narod, William D Foulkes. Nat Rev Cancer 2004
623
12

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
B Górski, T Byrski, T Huzarski, A Jakubowska, J Menkiszak, J Gronwald, A Pluzańska, M Bebenek, L Fischer-Maliszewska, E Grzybowska,[...]. Am J Hum Genet 2000
207
12

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Tom Walsh, Silvia Casadei, Kathryn Hale Coats, Elizabeth Swisher, Sunday M Stray, Jake Higgins, Kevin C Roach, Jessica Mandell, Ming K Lee, Sona Ciernikova,[...]. JAMA 2006
449
12

European ancestry is positively associated with breast cancer risk in Mexican women.
Laura Fejerman, Isabelle Romieu, Esther M John, Eduardo Lazcano-Ponce, Scott Huntsman, Kenneth B Beckman, Eliseo J Pérez-Stable, Esteban González Burchard, Elad Ziv, Gabriela Torres-Mejía. Cancer Epidemiol Biomarkers Prev 2010
67
12

[Available resources for the treatment of breast cancer in Mexico].
Alejandro Mohar, Enrique Bargalló, Ma Teresa Ramírez, Fernando Lara, Arturo Beltrán-Ortega. Salud Publica Mex 2009
39
12

Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010.
Benjamin O Anderson, Eduardo Cazap, Nagi S El Saghir, Cheng-Har Yip, Hussein M Khaled, Isabel V Otero, Clement A Adebamowo, Rajendra A Badwe, Joe B Harford. Lancet Oncol 2011
204
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.